2025-08-26 - Analysis Report
Okay, here's a comprehensive analysis of Merck & Co. Inc. (MRK) based on the data provided.

## Merck & Co. Inc. (MRK) Stock Analysis

Merck & Co. Inc. is a global pharmaceutical company that develops and markets a wide range of medicines and vaccines.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** -7.05%
*   **VOO (S&P 500) Cumulative Return:** 38.23%
*   **Absolute Divergence:** -43.6 (MRK underperformed VOO by 43.6%)
*   **Relative Divergence:** 4.3 (MRK's performance is near the bottom of its historical divergence range compared to VOO.)

**Analysis:** MRK has significantly underperformed the S&P 500. The relative divergence suggests that this underperformance is near the worst it has been historically.

### 2. Alpha, Beta Analysis

| Year       | CAGR     | MDD      | Alpha    | Beta     | Cap (B) |
|------------|----------|----------|----------|----------|---------|
| 2015-2017  | 5.0%     | 58.2%    | 5.0%     | 1.0      | 134.1   |
| 2016-2018  | 43.0%    | 66.4%    | 43.0%    | 1.0      | 182.1   |
| 2017-2019  | 40.0%    | 66.4%    | 40.0%    | 1.0      | 216.8   |
| 2018-2020  | 20.0%    | 66.4%    | 20.0%    | 1.0      | 195.0   |
| 2019-2021  | -1.0%    | 65.6%    | -2.0%    | 0.0      | 191.4   |
| 2020-2022  | 13.0%    | 69.5%    | 24.0%    | -0.0     | 277.1   |
| 2021-2023  | 31.0%    | 69.5%    | 22.0%    | -0.0     | 272.3   |
| 2022-2024  | -7.0%    | 69.5%    | -37.0%    | -0.0     | 248.5   |
| 2023-2025  | -59.0%   | 71.5%    | -103.0%   | 0.0      | 213.1   |

**Analysis:**

*   **Recent Performance Deterioration:** The CAGR (Compound Annual Growth Rate) has significantly declined in recent periods, turning sharply negative in the 2023-2025 timeframe.
*   **High MDD (Maximum Drawdown):** MDD values are consistently high, indicating substantial potential losses for investors during the observed periods.
*   **Alpha Decline:** The alpha, which measures performance relative to a benchmark, has become increasingly negative, especially in the most recent period (-103.0%), indicating significant underperformance compared to the benchmark.
*   **Beta Near Zero:** Beta is consistently near zero, indicating that the stock's price movements are largely independent of the overall market.

### 3. Recent Price Action

*   **Current Price:** \$85.31
*   **Previous Close:** \$87.37
*   **Change:** -\$2.36
*   **5-Day Moving Average:** \$85.67
*   **20-Day Moving Average:** \$82.28
*   **60-Day Moving Average:** \$81.26

**Analysis:** The price decreased from previous close, which is a notable drop, the price is currently below the 5-day moving average but above the 20-day and 60-day moving averages. This suggests a recent dip, but the longer-term trend might still be upward.

### 4. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3237 (Low Risk)
*   **RSI:** 67.12 (Approaching Overbought)
*   **PPO:** 0.6098 (Positive Momentum)
*   **Hybrid Signal:** "cash\_0%\_Buy 80% of cash (2 shares - Caution - MRI:0.33)"
*   **Recent (20-day) Relative Divergence Change:** 2.7 (+) (Short-term increase)
*   **Expected Return:** 934.1% (Long-term potential outperformance vs. S&P 500)

**Analysis:**

*   **Low Risk (MRI):** The MRI indicates a low level of market risk.
*   **RSI Near Overbought:** The RSI approaching 70 suggests the stock might be approaching overbought conditions.
*   **Positive Momentum (PPO):** The PPO indicates positive momentum.
*   **Hybrid Signal Cautious Buy:** The hybrid signal recommends buying with caution.
*   **Short-Term Improvement:** The increase in relative divergence over the last 20 days suggests some recent improvement.
*   **High Expected Return:** The very high expected return suggests significant long-term potential, but should be viewed with skepticism given the recent underperformance.
*   **Price drop Impact**: The price drop from previous close indicates there might have been an issue and should be investigated.

### 5. Recent News & Significant Events

*   **Volatility & Market Influence:** MRK's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **Analyst Discussions:** Analysts are discussing MRK's recent performance and its outlook in the context of industry trends and global economic factors.
*   **Major Business Developments & Regulatory Changes:** MRK has recently made headlines due to major business developments, regulatory changes, or market events.
*   **Expert Advice:** Market experts highlight both risks and opportunities, advising investors to monitor recent news and company announcements.

**Analysis:** Recent news suggests volatility and significant events affecting the stock. Staying informed about these developments is crucial for investors.

### 6. Recent Earnings Analysis

| 날짜       | EPS  | 매출         |
|------------|------|--------------|
| 2025-08-05 | 1.76 | 15.81 B$    |
| 2025-05-02 | 2.01 | 15.53 B$    |
| 2024-11-06 | 1.25 | 16.66 B$    |
| 2024-08-05 | 2.15 | 16.11 B$    |
| 2025-08-05 | 2.15 | 16.11 B$    |

**Analysis:**

*   **Mixed EPS:** EPS (Earnings Per Share) has fluctuated.
*   **Relatively Stable Revenue:** Revenue has been relatively stable, with some quarterly variations.

### 7. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | \$15.81B  | 77.50%        |
| 2025-03-31 | \$15.53B  | 77.98%        |
| 2024-12-31 | \$15.62B  | 75.50%        |
| 2024-09-30 | \$16.66B  | 75.51%        |
| 2024-06-30 | \$16.11B  | 76.76%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | \$48.99B  | 9.04%     |
| 2025-03-31 | \$48.34B  | 10.51%    |
| 2024-12-31 | \$46.31B  | 8.08%     |
| 2024-09-30 | \$44.50B  | 7.09%     |
| 2024-06-30 | \$43.58B  | 12.52%    |

**Analysis:**

*   **Stable Revenue:** Revenue has been relatively consistent across the quarters.
*   **High Profit Margins:** Profit margins are very high, consistently above 75%, indicating strong profitability.
*   **Increasing Equity:** Equity has been generally increasing, suggesting growth in the company's net assets.
*   **Fluctuating ROE:** ROE (Return on Equity) has fluctuated, with a recent dip.

### 8. Overall Summary

**Key Observations:**

*   **Underperformance:** MRK has significantly underperformed the S&P 500 recently. The price decrease from previous close indicates there might have been an issue and should be investigated.
*   **Declining Alpha:** Alpha has declined significantly.
*   **Recent Volatility:** News suggests recent volatility and significant events affecting the stock.
*   **High Profitability:** The company maintains high profit margins.
*   **Cautious Buy Signal:** Hybrid signal suggests buying with caution.
*   **Long-Term Potential (Uncertain):** Extremely high expected return, but recent underperformance makes this less credible.

**Investment Recommendation:**

Based on the data provided, a cautious approach to investing in MRK is warranted. The recent underperformance and mixed signals from technical indicators suggest potential risks. The high expected return should be regarded with skepticism. Investors should closely monitor news, earnings reports, and analyst opinions to make informed decisions. The recent price decrease from previous close should be investigated.
